Sponsor of the Day:
Jerkmate
https://apellis.com/
Official Home Page of the Apellis Pharmaceuticals Corporate Site | Apellis Pharmaceuticals
Jul 29, 2025 - Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are...
corporate siteofficialapellispharmaceuticals
https://markets.financialcontent.com/stocks/quote?Symbol=537%3A30132056
FinancialContent - Apellis Pharmaceuticals, Inc. - Common Stock (Nasdaq:APLS) Stock Quote
View live stock data, charting, and news for Apellis Pharmaceuticals, Inc. - Common Stock (Nasdaq:APLS)
inc common stockfinancialcontentapellispharmaceuticalsnasdaq
https://www.biospace.com/business/biogen-secures-running-start-in-kidney-disease-with-5-6b-apellis-buy
Biogen Secures ‘Running Start’ in Kidney Disease With $5.6B Apellis Buy - BioSpace
Mar 31, 2026 - In addition to delivering two approved medicines to Biogen’s portfolio, the acquisition of Apellis Pharmaceuticals will support the future launch of the...
kidney disease5 6bbiogensecuresapellis
https://www.statnews.com/2026/03/31/biotech-news-psychedelic-startups-face-scrutiny-over-youtube-promo/
Eli Lilly, Apellis, Gilead, Helus Pharma: Readout Newsletter
Mar 31, 2026 - Today's biotech news covers Biogen and Eli Lilly making takeover moves, Doctors Without Borders slamming Gilead, and more
eli lillyhelus pharmareadout newsletterapellisgilead
https://www.genengnews.com/topics/translational-medicine/lilly-acquires-centessa-for-up-to-7-8b-biogen-buys-apellis-for-up-to-6-1b/
Lilly Acquires Centessa for Up to $7.8B; Biogen Buys Apellis for Up to $6.1B
Mar 31, 2026 - Eli Lilly agrees to acquire sleep disorder drug developer Centessa Pharmaceuticals for approximately $7.8 billion, while Biogen agrees to purchase Apellis...
7 8b6 1blillyacquirescentessa